GreenLight Biosciences Blog

Breaking the Vaccine Production Bottleneck: How to make a Messenger RNA vaccine

GreenLight Biosciences is working on a Messenger RNA vaccine. In this piece, the team explains why a Messenger RNA vaccine is so vital and how to make it.

Read More

Five Question Friday: Archie Mathura

Meet Archie, December’s Question Friday participant! Archie is GreenLight’s corporate controller, where she supports the company’s accounting, financial reporting, taxes and payroll programs.

#WFH Series: Elisha Fielding

Up next in our work from home series is Elisha Fielding, Ph.D., Senior Scientist, Biochemist at GreenLight. Elisha shares her work from home hacks and how she stays connected to colleagues during this time. Check out Elisha’s full responses below.

#WFH Series: Evelien Van Ekert

This week, meet Evelien Van Ekert, Ph.D., Scientist III, Crop Protection at GreenLight. Evelien shares her work from home tips, some special art from her kids, and ways to stay connected to coworkers. Read more below!

Five Question Friday: Upendra Devisetty

Meet Upendra, this month’s 5 Question Friday participant! Upendra is a data scientist at GreenLight, working on both crop protection and human health projects. He enjoys using his skills in data science and bioinformatics to help contribute to multiple projects simultaneously.

#WFH Series: Matt Moura

This week in the GreenLight #WFH series, we connected with Matthew Moura, Ph.D., Senior Scientist, Pathway Engineer at GreenLight. Check out Matthew’s tips and tricks for his home office, some memorable items for motivation, and ways to stay connected with co-workers.

#WFH Series: Kestrel McCorkle

This week, we’re kicking off our work from home series with Kestrel McCorkle, Ph.D., Scientist III, Crop Protection. Check out a few tips, tricks, and even board games below!

Five Question Friday: Oscar Pardo, Ph.D.

Meet this month’s 5 Question Friday spotlight – Oscar Pardo, an engineer on the Process Science team. Oscar works on process development of GreenLight’s cell-free reaction in plant and human health projects.

GreenLight Biosciences Receives $3.3 Million Grant

BOSTON, Sept. 15, 2020 — GreenLight Biosciences has received a $3.3 million grant from the Bill & Melinda Gates Foundation to develop new mRNA-based gene therapies for Sickle Cell Disease and other global health challenges.

Five Question Friday: Ethann Barnes

This month, Ethann Barnes, Biology Data Management Scientist, answers five questions about his experience with the company, his background and hobbies.

Five Question Friday: Jo Tang

This month, Jo Tang, Project Manager, answers five questions about her experience with the company, her background and hobbies.

The New Normal

I was recently on a Zoom call with hundreds of young people explaining our company’s large-scale manufacturing process for a SARS-CoV2 vaccine. They all wanted to know one thing: how can we get back to the way things were? How do we get back to normal?

If the Bugs Go, We Go

In the last week, a group of Australian and Chinese scientists published a review article describing the results of a number of studies conducted by approximately 50 research groups around the globe over the last decade.

Join the GreenLight Revolution

Learn more about how GreenLight Biosciences is enabling innovative technologies to protect the health of people and the planet. We are always looking to meet new partners, new colleagues or anyone interested to learn more about RNA.